# Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy

> **NCT04056533** · PHASE2 · RECRUITING · sponsor: **Instituto de Investigación Marqués de Valdecilla** · enrollment: 15 (estimated)

## Conditions studied

- CMV

## Interventions

- **BIOLOGICAL:** CMV CTLs

## Key facts

- **NCT ID:** NCT04056533
- **Lead sponsor:** Instituto de Investigación Marqués de Valdecilla
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-26
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2024-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04056533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04056533, "Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04056533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*